Back to Search
Start Over
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.
- Source :
-
Blood Pressure . Dec2022, Vol. 31 Issue 1, p164-168. 5p. - Publication Year :
- 2022
-
Abstract
- One relatively simple and potentially scalable approach to improving hypertension control is greater use of single-pill combinations (SPC) containing two or more different classes of antihypertensive medications as initial and add-in therapy [[4], [6], [8], [10], [12]]. 5 ComboRx: combination treatment with two anti-hypertensive medication either as a single-pill or separate pill; SPC: single-pill combination antihypertensive therapy; FEC: free equivalent combination single antihypertensive medication, two antihypertensive medications as two separate pills with same medications comparator SPC. SPC accounted for 6.3% of antihypertensive medication prescriptions and 12.3% of antihypertensive medications within the top 300 (Table 3) [[21]]. Thus, it often takes two years or more of uncontrolled hypertension before antihypertensive medication is added or the dose increased for an existing medication. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 08037051
- Volume :
- 31
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- Blood Pressure
- Publication Type :
- Academic Journal
- Accession number :
- 160300914
- Full Text :
- https://doi.org/10.1080/08037051.2022.2095254